Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-Mar-23 4:41 PM View:  | BioCryst Pharmaceuticals Inc. (BCRX) | 28-Feb-23 | Grant | 2,259 | $8.85 | $19,992.20 | 2% 97.94K to 100.2K | |
| 19-Dec-22 9:14 PM View: | Black Diamond Therapeutics,... (BDTX) | 16-Dec-22 | Grant | 9,375 | $1.50 | $14,062.50 | 28% 33.48K to 42.85K | |
| 02-Dec-22 6:24 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 30-Nov-22 | Grant | 1,497 | $13.36 | $19,999.90 | 2% 96.44K to 97.94K | 11% |
| 19-Sep-22 5:08 PM View: | Black Diamond Therapeutics,... (BDTX) | 16-Sep-22 | Grant | 6,584 | $2.62 | $17,250.10 | 24% 26.89K to 33.48K | |
| 02-Sep-22 4:31 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Aug-22 | Grant | 1,438 | $13.90 | $19,988.20 | 2% 95.0K to 96.44K | 6% |
| 17-Jun-22 4:25 PM View: | Black Diamond Therapeutics,... (BDTX) | 17-Jun-22 | Grant | 8,498 | $2.03 | $17,250.90 | 46% 18.4K to 26.89K | |
| 09-Jun-22 4:50 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 07-Jun-22 | Grant | 12,866 | -- | -- | 16% 82.14K to 95.0K | |
| 02-Jun-22 4:34 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 31-May-22 | Grant | 2,078 | $9.31 | $19,346.20 | 3% 80.06K to 82.14K | |
| 18-Mar-22 4:05 PM View: | Black Diamond Therapeutics,... (BDTX) | 18-Mar-22 | Grant | 5,795 | $3.02 | $17,500.90 | 46% 12.6K to 18.4K | |
| 02-Mar-22 4:40 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 28-Feb-22 | Grant | 1,128 | $16.61 | $18,736.10 | 1% 78.93K to 80.06K | |
| 17-Dec-21 4:12 PM View: | Black Diamond Therapeutics,... (BDTX) | 17-Dec-21 | Grant | 3,296 | $5.31 | $17,501.80 | 35% 9.31K to 12.6K | 0% |
| 02-Dec-21 4:08 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 30-Nov-21 | Grant | 1,554 | $12.06 | $18,741.20 | 2% 77.38K to 78.93K | (7%) |
| 23-Sep-21 10:00 PM View: | Black Diamond Therapeutics,... (BDTX) | 17-Sep-21 | Grant | 1,869 | $9.90 | $18,503.10 | 25% 7.44K to 9.31K | (6%) |
| 02-Sep-21 4:33 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Aug-21 | Grant | 1,177 | $15.92 | $18,737.80 | 2% 76.2K to 77.38K | 1% |
| 22-Jun-21 6:13 PM View: | Black Diamond Therapeutics,... (BDTX) | 18-Jun-21 | Grant | 1,255 | $12.95 | $16,252.20 | 20% 6.18K to 7.44K | (4%) |
| 01-Jun-21 4:27 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 28-May-21 | Grant | 1,188 | $15.77 | $18,734.80 | 2% 75.01K to 76.2K | 0% |
| 22-Mar-21 8:19 PM View: | Black Diamond Therapeutics,... (BDTX) | 18-Mar-21 | Grant | 677 | $24.01 | $16,254.80 | 12% 5.5K to 6.18K | 5% |
| 02-Mar-21 4:55 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 26-Feb-21 | Grant | 1,739 | $10.78 | $18,746.40 | 2% 73.27K to 75.01K | 11% |
| 16-Dec-20 7:42 PM View: | Black Diamond Therapeutics,... (BDTX) | 15-Dec-20 | Grant | 505 | $34.29 | $17,316.50 | 10% 5.0K to 5.5K | |
| 02-Dec-20 4:14 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 30-Nov-20 | Grant | 3,669 | $5.11 | $18,748.60 | 5% 69.61K to 73.27K | 49% |
| 01-Oct-20 4:06 PM View: | Black Diamond Therapeutics,... (BDTX) | 30-Sep-20 | Purchase | 5,000 | $30.46 | $152,285.00 | 100% 0 to 5.0K | |
| 02-Sep-20 4:33 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Aug-20 | Grant | 4,518 | $4.15 | $18,749.70 | 7% 65.09K to 69.61K | 83% |
| 03-Jun-20 4:16 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jun-20 | Grant | 4,171 | $4.49 | $18,748.60 | 7% 60.92K to 65.09K | 69% |
| 03-Mar-20 4:47 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Mar-20 | Grant | 6,250 | $3.00 | $18,750.00 | 11% 54.67K to 60.92K | 151% |
| 03-Dec-19 5:09 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Dec-19 | Grant | 6,578 | $2.85 | $18,747.30 | 14% 48.09K to 54.67K | 163% |
| 18-Nov-19 4:12 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 18-Nov-19 | Private Purchase | 20,000 | $1.45 | $29,000.00 | 71% 28.09K to 48.09K | |
| 04-Sep-19 4:08 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Sep-19 | Grant | 6,270 | $2.99 | $18,747.30 | 29% 21.82K to 28.09K | 152% |
| 23-May-19 8:31 AM View: | Novan, Inc. (NOVN) | 22-May-19 | Market Purchase | 50,000 | $2.21 | $110,500.00 | 42% 119.78K to 169.78K | 5% |
| 18-Oct-18 4:19 PM View: | Cree Inc. (CREE) | 17-Oct-18 | Grant | 760 | $39.46 | $29,989.60 | < 1% 76.95K to 77.71K | 105% |
| 01-Oct-18 4:34 PM View: | Novan, Inc. (NOVN) | 28-Sep-18 | Market Purchase | 50,000 | $2.84 | $142,000.00 | 72% 69.78K to 119.78K | (58%) |
| 31-Aug-18 4:14 PM View: | Cree Inc. (CREE) | 30-Aug-18 | Option Exercise | 4,000 | $30.92 | $123,680.00 | 5% 72.95K to 76.95K | |
| 16-Aug-18 4:19 PM View: | Cree Inc. (CREE) | 15-Aug-18 | Grant | 648 | $46.26 | $29,976.50 | < 1% 72.3K to 72.95K | 75% |
| 04-Jun-18 2:54 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jun-18 | Grant | 2,916 | $6.43 | $18,749.90 | 15% 18.9K to 21.82K | 17% |
| 27-Apr-18 4:41 PM View: | Cree Inc. (CREE) | 25-Apr-18 | Grant | 764 | $39.25 | $29,987.00 | 1% 71.54K to 72.3K | 106% |
| 02-Mar-18 2:14 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Mar-18 | Grant | 3,772 | $4.97 | $18,746.80 | 25% 15.13K to 18.9K | 52% |
| 26-Jan-18 4:17 PM View: | Cree Inc. (CREE) | 24-Jan-18 | Grant | 833 | $35.98 | $29,971.30 | 1% 70.7K to 71.54K | 124% |
| 04-Dec-17 3:53 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Dec-17 | Grant | 3,690 | $5.08 | $18,745.20 | 32% 11.44K to 15.13K | 48% |
| 20-Oct-17 4:20 PM View: | Cree Inc. (CREE) | 18-Oct-17 | Grant | 731 | $34.16 | $24,971.00 | 1% 69.97K to 70.7K | 136% |
| 05-Sep-17 11:29 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Sep-17 | Grant | 3,676 | $5.10 | $18,747.60 | 47% 7.76K to 11.44K | 48% |
| 06-Sep-17 4:23 PM View: | Cree Inc. (CREE) | 01-Sep-17 | Grant | 7,033 | -- | -- | 11% 62.94K to 69.97K | |
| 29-Aug-17 4:37 PM View: | Novan, Inc. (NOVN) | 29-Aug-17 | Market Purchase | 8,465 | $4.70 | $39,785.50 | 14% 61.31K to 69.78K | (75%) |
| 29-Aug-17 4:37 PM View: | Novan, Inc. (NOVN) | 25-Aug-17 | Market Purchase | 3,535 | $4.25 | $15,023.80 | 6% 57.78K to 61.31K | (72%) |
| 24-Aug-17 4:13 PM View: | Cree Inc. (CREE) | 23-Aug-17 | Grant | 1,125 | $22.21 | $24,986.20 | 2% 61.82K to 62.94K | 263% |
| 02-Jun-17 4:04 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jun-17 | Grant | 1,941 | $5.15 | $9,996.15 | 33% 5.82K to 7.76K | 46% |
| 27-Apr-17 4:27 PM View: | Cree Inc. (CREE) | 26-Apr-17 | Grant | 1,132 | $22.07 | $24,983.20 | 2% 60.68K to 61.82K | 266% |
| 04-Apr-17 5:53 PM View: | Valeant Pharmaceuticals Int... (BHC) | 31-Mar-17 | Grant | 2,120 | $11.03 | $23,383.60 | 2% 89.93K to 92.05K | 115% |
| 02-Mar-17 3:07 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 02-Mar-17 | Grant | 1,602 | $6.24 | $9,996.48 | 38% 4.22K to 5.82K | 10% |
| 26-Jan-17 4:28 PM View: | Cree Inc. (CREE) | 25-Jan-17 | Grant | 867 | $28.83 | $24,995.60 | 1% 59.82K to 60.68K | 180% |
| 04-Jan-17 7:45 PM View: | Valeant Pharmaceuticals Int... (BHC) | 30-Dec-16 | Grant | 1,463 | $14.52 | $21,242.80 | 2% 88.46K to 89.93K | 63% |
| 02-Dec-16 2:09 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Dec-16 | Grant | 1,788 | $5.59 | $9,994.92 | 73% 2.43K to 4.22K | 35% |